abstract |
The present disclosure relates to methods of making solid pharmaceutical compositions comprising cannabinoids, wherein said compositions comprise one or more cannabinoid extracts, lipophilic solvents, and porous particulate solids; and kits, methods of manufacture, and methods of use thereof. |